Richard Baugh

Post-Doctoral Research Fellow working on Oncolytic Virotherapy at the University of Leeds

[Richard Baugh @RichardBaugh3]

A huge thank you to the @BCRT for organising such fantastic conferences, and to @Sarcoma_UK for funding my research. (3/3)
#SarcomaAwarenessMonth #EwingSarcoma #CancerResearch #Immunotherapy #BoneCancer #SarcomaResearch

[Richard Baugh @RichardBaugh3]

Just back from an inspiring few days in London at the @euroewing & Advances in Ewing Sarcoma Research meetings — two fantastic events bringing together researchers, clinicians, and advocates working to improve outcomes for people affected by Ewing sarcoma. (1/3)

[Richard Baugh @RichardBaugh3]

It was an privilege representing @LIMRLeeds and @UniversityLeeds to present a poster on some of our work exploring novel immunotherapies for Ewing sarcoma, and I was honoured to be awarded the Poster Prize! 🎉 (2/3)

[Richard Baugh @RichardBaugh3]

Delighted for the opportunity to represent @LIMRLeeds and present some of our research at #EuSARC24 exploring novel immunotherapies for the treatment of #Ewingsarcoma

Thanks @BCRT for making attendance possible with their travel grant!
@eu_sarc @Sarcoma_UK

[Brain Research UK @BRUKresearch]

Brilliant work by @RichardBaugh3, funded by one of our PhD studentships, offering a new strategy for targeting treatment-resistant cancer stem cells in glioblastoma.

[Richard Baugh @RichardBaugh3]

Delighted to share our new manuscript published this week in @JITC showcasing a novel oncolytic herpes simplex virus armed to express a Bi-specific T cell Engager which targets NKG2D ligands in glioblastoma.

@Oncolytics_oxon
@OxfordOncology
@BRUKresearch

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells https://t.co/VIHaapI1Ll @RichardBaugh3 @wktpeter

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells https://t.co/VIHaapI1Ll @RichardBaugh3 @wktpeter

[Bone Cancer Research Trust @BCRT]

Dr Richard Baugh @LeedsMedHealth @LTHTResearch is up next, presenting research evaluating the effect of pro-inflammatory cytokines on oncolysis mediated by the oncolytic virus coxsackievirus A-21 in patient-derived Ewing sarcoma cell cultures #AESR

[Sarcoma UK @Sarcoma_UK]

Fiona and team at @UniversityLeeds are working on 'cancer-bursting' viruses, which can invade Ewing sarcoma cells directly or make our immune systems attack and kill the cancer.

#BoneCancerAwarenessWeek

https://t.co/RdY6EP2FOy

[Richard Baugh @RichardBaugh3]

@RhodW Thank you! Of course! 😂

[Richard Baugh @RichardBaugh3]

Today marks my last day at the University of Oxford after almost 10 years. I have had the honour of meeting and working alongside some amazing and incredibly talented people, who I will miss dearly.

[Richard Baugh @RichardBaugh3]

Thank you from the bottom of my heart to everyone that has helped make my time here such an enjoyable experience over the years.

Now, a new adventure awaits at the University of Leeds!

@Oncolytics_oxon @OxfordOncology

[Oncology Post-doc Network @OPN_OxfordUni]

Thank you all for coming to the @OxfordOncology @The_OIRO post-doc #Christmas social! Happy Christmas & New Year's! @onco_hannah @_anjaliarora @TessStanly @RichardBaugh3 @nuriavl1993 @SusannaPhyu @halaestephan @ScottCo85123133

[Seymour Lab Oxford @Oncolytics_oxon]

Some highlights from last week when members of the Seymour Lab presented their brilliant research at the 14th International Oncolytic Virus Conference 2022 in Karuizawa, Japan

#IOVC22

[Richard Baugh @RichardBaugh3]

@OPN_OxfordUni Thank you! And thank you for arranging such a great event!

[Oncology Post-doc Network @OPN_OxfordUni]

@RichardBaugh3 from Len Seymour lab, giving his talk on bispecific #Tcell engagers- BiTE for #virotherapy of glioblastoma at the postdoc away day @OxfordOncology

[Richard Baugh @RichardBaugh3]

@eileen_parkes @Oncolytics_oxon @LamfersMartine @BRUKresearch Thanks so much! 🎉

[Richard Baugh @RichardBaugh3]

@BRUKresearch Thank you for all the support throughout!

[Brain Research UK @BRUKresearch]

🎉Enormous congratulations to Dr Richard Baugh, who successfully defended his DPhil thesis last week 🎉 We're proud to have supported him through his DPhil; read about his research, focused on the immunotherapy of glioblastoma here 👉https://t.co/AsqqRo5R0T

[Seymour Lab Oxford @Oncolytics_oxon]

Congratulations to Dr @RichardBaugh3 who successfully defended his DPhil thesis last week! Many thanks to the wonderful examiners @eileen_parkes and @LamfersMartine

@BRUKresearch